Ultragenyx Pharmaceutical, Inc. (RARE)
24.77
+0.08
(+0.32%)
USD |
NASDAQ |
May 01, 16:00
24.76
-0.01
(-0.04%)
After-Hours: 20:00
Ultragenyx Pharmaceutical Market Cap : 2.394B for May 1, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Catalyst Pharmaceuticals, Inc. | 3.510B |
| BioMarin Pharmaceutical, Inc. | 10.40B |
| Regeneron Pharmaceuticals, Inc. | 73.54B |
| Xencor, Inc. | 930.67M |
| REGENXBIO, Inc. | 470.71M |
Market Cap Related Metrics
| PS Ratio | 3.631 |
| Price | 24.77 |
| Earnings Yield | -23.56% |